KV7 potassium channels: A new therapeutic target in smooth muscle disorders

Drug Discovery Today

Volumn 19, Issue 4, 2014, Pages 413-424

  Stott, Jennifer B ^a   Jepps, Thomas A ^a   Greenwood, Iain A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALMODULIN; FLUPIRTINE; LINOPIRDINE; POTASSIUM CHANNEL KV7; RETIGABINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ;

ASTHMA; CARDIOVASCULAR DISEASE; CELL MEMBRANE; DRUG TARGETING; HUMAN; HYPERPOLARIZATION; HYPERTENSION; MUSCLE DISEASE; NONHUMAN; PATHOGENESIS; PREMATURE LABOR; REVIEW; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE TONE; URINE INCONTINENCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; FEMALE; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SMOOTH MUSCLE; VASCULAR DISEASE;

ANIMALS; ASTHMA; FEMALE; HUMANS; KCNQ POTASSIUM CHANNELS; MUSCLE, SMOOTH; MUSCULAR DISEASES; OBSTETRIC LABOR, PREMATURE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PREGNANCY; URINARY INCONTINENCE; VASCULAR DISEASES;

EID: 84899522511     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.12.003     Document Type: Review

References (162)

1. W.C. Cole, and D.G. Welsh Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure Arch. Biochem. Biophys. 510 2011 160 173
2. K.K. Bradley et al. Kir2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells J. Physiol. 515 1999 639 651
3. +-mediated vasodilation Circ. Res. 87 2000 160 166
4. J.M. Quayle et al. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle Physiol. Rev. 77 1997 1165 1232
5. + channels in vascular smooth muscle cells Pflugers Arch. 457 2008 137 147
6. J.M. Quayle et al. The properties and distribution of inward rectifier potassium currents in pig coronary arterial smooth muscle J. Physiol. 494 1996 715 726
7. J.G. McCarron, and W. Halpern Potassium dilates rat cerebral arteries by two independent mechanisms Am. J. Physiol. 259 1990 H902 H908
8. S.P. Marrelli et al. Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion Stroke 29 1998 1469 1474
9. ATP channelopathies: diseases of metabolic homeostasis Pflugers Arch. 460 2010 295 306
10. + channels in smooth muscle J. Physiol. 572 2006 617 624
11. + channel in the rabbit portal vein J. Physiol. 444 1991 397 418
12. S. Kajioka et al. Nicorandil opens a calcium-dependent potassium channel in smooth muscle cells of the rat portal vein J. Pharmacol. Exp. Ther. 254 1990 905 913
13. + channels in arterial smooth muscle Science 245 1989 177 180
14. + channel and enhanced vascular smooth muscle relaxation in genetically hypertensive rats J. Hypertens. 11 1993 1067 1072
15. S. Matzno et al. The effect of AL0671, a novel potassium channel opener, on potassium current in rat aortic smooth muscle cells Gen. Pharmacol. 26 1995 1327 1334
16. ATP channels in vascular smooth muscle Clin. Exp. Pharmacol. Physiol. 29 2002 312 316
17. Z. Pan et al. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim J. Cardiovasc. Pharmacol. 56 2010 215 228
18. H. Mori et al. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel Am. J. Physiol. 268 1995 H1077 H1085
19. S.M. Gardiner et al. Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats Br. J. Pharmacol. 117 1996 507 515
20. J.E. Brayden Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation Am. J. Physiol. 259 1990 H668 H673
21. + channel blockers on vascular tone in the perfused rat lung Am. Rev. Respir. Dis. 144 1991 884 887
22. M.D. Randall, and A.I. McCulloch The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed Br. J. Pharmacol. 115 1995 607 612
23. M. Nakashima, and P.M. Vanhoutte Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein J. Pharmacol. Exp. Ther. 272 1995 379 384
24. T. Miki et al. Mouse model of prinzmetal angina by disruption of the inward rectifier Kir6.1 Nat. Med. 8 2002 466 472
25. ATP channels J. Clin. Invest. 110 2002 203 208
26. R. Kakkar et al. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process Circ. Res. 98 2006 682 689
27. ATP channel currents in vascular smooth muscle cells from deoxycorticosterone acetate (DOCA)-salt hypertensive rats J. Cardiovasc. Pharmacol. 44 2004 525 531
28. A. Adebiyi et al. Vasodilation induced by oxygen/glucose deprivation is attenuated in cerebral arteries of SUR2 null mice Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1360 H1368
29. M.T. Nelson, and J.M. Quayle Physiological roles and properties of potassium channels in arterial smooth muscle Am. J. Physiol. 268 1995 C799 C822
30. + channels in vascular smooth muscle cells J. Smooth Muscle Res. 44 2008 65 81
31. Ca) and arteriolar myogenic signaling FEBS Lett. 584 2010 2033 2042
32. + channel in vascular smooth muscle cells Drug Discov. Today 17 2012 974 987
33. Z. Jiang et al. Human and rodent MaxiK channel beta-subunit genes: cloning and characterization Genomics 55 1999 57 67
34. R. Brenner et al. Vasoregulation by the beta1 subunit of the calcium-activated potassium channel Nature 407 2000 870 876
35. M. Sausbier et al. Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice Circulation 112 2005 60 68
36. + current is enhanced in arterial membranes of hypertensive rats Hypertension 19 1992 301 307
37. + current in arterial membranes from genetically hypertensive rats Am. J. Physiol. 264 1993 H1337 H1345
38. + channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats Br. J. Pharmacol. 108 1993 214 222
39. 2+-dependent K-channels in the membrane potential and contractility of aorta from spontaneously hypertensive rats Br. J. Pharmacol. 113 1994 1022 1028
40. + channels in aorta of hypertensive rats Hypertension 30 1997 1403 1409
41. H. Xu et al. Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats Hypertension 46 2005 1154 1162
42. + channel beta1-subunit knockout mice are not hypertensive Am. J. Physiol. Heart Circ. Physiol. 300 2011 H476 H485
43. C.A. Sargent et al. The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004 J. Pharmacol. Exp. Ther. 266 1993 1422 1429
44. J.H. Sheldon et al. Inhibition of guinea pig detrusor contraction by NS-1619 is associated with activation of BKCa and inhibition of calcium currents J. Pharmacol. Exp. Ther. 283 1997 1193 1200
45. C.M. Sorensen et al. Role of vascular potassium channels in the regulation of renal hemodynamics Am. J. Physiol. Renal Physiol. 302 2012 F505 F518
46. W.F. Jackson Ion channels and vascular tone Hypertension 35 2000 173 178
47. + channels in the resting state of cerebral, coronary and mesenteric arteries of the dog J. Pharmacol. Exp. Ther. 267 1993 1277 1285
48. Ca channels: an update on their pharmacology and usefulness as cardiovascular targets J. Cardiovasc. Pharmacol. 61 2013 102 112
49. G.V. Petkov Role of potassium ion channels in detrusor smooth muscle function and dysfunction Nat. Rev. Urol. 9 2011 30 40
50. + channels depresses phasic uterine contraction Am. J. Physiol. Cell Physiol. 292 2007 C832 C840
51. H. Wulff et al. Voltage-gated potassium channels as therapeutic targets Nat. Rev. Drug Discov. 8 2009 982 1001
52. V.P. Korovkina, and S.K. England Molecular diversity of vascular potassium channel isoforms Clin. Exp. Pharmacol. Physiol. 29 2002 317 323
53. V7 potassium channels Physiology 26 2011 365 376
54. R.H. Cox Molecular determinants of voltage-gated potassium currents in vascular smooth muscle Cell Biochem. Biophys. 42 2005 167 195
55. N. Ottschytsch et al. Obligatory heterotetramerization of three previously uncharacterized KV channel alpha-subunits identified in the human genome Proc. Natl. Acad. Sci. U. S. A. 99 2002 7986 7991
56. V subunits: their molecular and functional characteristics Physiology 27 2012 73 84
57. V6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain J. Physiol. 587 2009 625 640
58. N.S. Cook Effect of some potassium channel blockers on contractile responses of the rabbit aorta J. Cardiovasc. Pharmacol. 13 1989 299 306
59. + channels of vascular smooth muscle Circ. Res. 89 2001 1030 1037
60. + channels in rat small cerebral arteries: molecular identity of the functional channels J. Physiol. 551 2003 751 763
61. + current in renal vascular smooth muscle Pflugers Arch. 445 2003 697 704
62. + current of rabbit vascular myocytes Circ. Res. 89 2001 1038 1044
63. V1 channels contribute to myogenic control of arterial diameter Circ. Res. 96 2005 216 224
64. + channels: a shared vasodilator defect of genetic and renal hypertensive rats Am. J. Physiol. Heart Circ. Physiol. 297 2009 H293 H303
65. Valpha1 subunits in terminal arterioles of rabbit J. Physiol. 534 2001 691 700
66. + channel currents in rat aortic myocytes Cardiovasc. Res. 54 2002 152 161
67. + channel in oxygen-sensitive pulmonary artery myocytes EMBO J. 16 1997 6615 6625
68. 2+ channels Am. J. Physiol. Heart Circ. Physiol. 283 2002 H247 H253
69. V2 channels oppose myogenic constriction of rat cerebral arteries Am. J. Physiol. Cell Physiol. 291 2006 C348 C356
70. X.Z. Zhong et al. Stromatoxin-sensitive, heteromultimeric KV2.1/KV9.3 channels contribute to myogenic control of cerebral arterial diameter J. Physiol. 588 2010 4519 4537
71. V4 subfamilies Mol. Pharmacol. 62 2002 48 57
72. + channel expression in arteries of Wistar-Kyoto and spontaneously hypertensive rats Am. J. Hypertens. 21 2008 213 218
73. 2+ store to the plasma membrane Nature 437 2005 902 905
74. + channels in vascular smooth muscle cells from rats made hypertensive with N{omega}-nitro-l-arginine Am. J. Physiol. Heart Circ. Physiol. 289 2005 H1284 H1290
75. + current in a vertebrate neurone Nature 283 1980 673 676
76. KS cardiac potassium current Nature 384 1996 78 80
77. KS potassium channel Nature 384 1996 80 83
78. N.A. Singh et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns Nat. Genet. 18 1998 25 29
79. C. Charlier et al. A pore mutation in a novel LQT-like potassium channel gene in an idiopathic epilepsy family Nat. Genet. 18 1998 53 55
80. C. Kubisch et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness Cell 96 1999 437 446
81. + channels implicate sensory outer hair cells in human progressive deafness EMBO J. 25 2006 642 652
82. V7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons Semin. Cell Dev. Biol. 22 2011 185 192
83. H. Wen, and I.B. Levitan Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels J. Neurosci. 22 2002 7991 8001
84. A. Etxeberria et al. Calmodulin regulates the trafficking of KCNQ2 potassium channels FASEB J. 22 2008 1135 1143
85. 2+/calmodulin Mol. Biol. Cell 16 2005 3538 3551
86. + current in cardiac myocytes Circ. Res. 96 2005 64 72
87. + channels J. Gen. Physiol. 122 2003 17 31
88. V7) potassium channels Nat. Rev. Neurosci. 6 2005 850 862
89. B.C. Suh, and B. Hille Regulation of KCNQ channels by manipulation of phosphoinositides J. Physiol. 582 2007 911 916
90. B.C. Suh, and B. Hille Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis Neuron 35 2002 507 520
91. C.P. Ford et al. Experiments to test the role of phosphatidylinositol 4,5-bisphosphate in neurotransmitter-induced M-channel closure in bullfrog sympathetic neurons J. Neurosci. 23 2003 4931 4941
92. + channel open probability by phosphatidylinositol 4,5-bisphosphate J. Neurosci. 25 2005 9825 9835
93. + channels EMBO J. 22 2003 5412 5421
94. Y. Haitin, and B. Attali The C-terminus of KV7 channels: a multifunctional module J. Physiol. 586 2008 1803 1810
95. Y. Kwon et al. Integration of phosphoinositide- and calmodulin-mediated regulation of TRPC6 Mol. Cell 25 2007 491 503
96. L. Shamgar et al. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations Circ. Res. 98 2006 1055 1063
97. F. Potet et al. AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IKS channel complex Am. J. Physiol. Heart Circ. Physiol. 280 2001 H2038 H2045
98. J. Kurokawa et al. Regulatory actions of the A-kinase anchoring protein Yotiao on a heart potassium channel downstream of PKA phosphorylation Proc. Natl. Acad. Sci. U. S. A. 101 2004 16374 16378
99. L. Chen et al. Mutation of an A-kinase-anchoring protein causes long-QT syndrome Proc. Natl. Acad. Sci. U. S. A. 104 2007 20990 20995
100. H.S. Wang et al. Molecular basis for differential sensitivity of KCNQ and IKS channels to the cognitive enhancer XE991 Mol. Pharmacol. 57 2000 1218 1223
101. H.S. Jensen et al. The KCNQ5 potassium channel from mouse: a broadly expressed M-current like potassium channel modulated by zinc, pH, and volume changes Brain Res. Mol. Brain Res. 139 2005 52 62
102. V7 channels in murine vascular reactivity Br. J. Pharmacol. 151 2007 758 770
103. D.S. Dupuis et al. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352 Eur. J. Pharmacol. 437 2002 129 137
104. A.M. Costa, and B.S. Brown Inhibition of M-current in cultured rat superior cervical ganglia by linopirdine: mechanism of action studies Neuropharmacology 36 1997 1747 1753
105. J.A. Lamas et al. Effects of a cognition-enhancer, linopirdine (DuP 996), on M-type potassium currents (IK(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons Eur. J. Neurosci. 9 1997 166 605
106. H.S. Wang et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel Science 282 1998 1890 1893
107. G. Seebohm et al. Molecular determinants of KCNQ1 channel block by a benzodiazepine Mol. Pharmacol. 64 2003 70 77
108. G.C. Bett et al. Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel J. Physiol. 576 2006 755 767
109. KS stably expressed in HEK 293 cells J. Membr. Biol. 210 2006 183 192
110. C. Lerche et al. Chromanol 293B binding in KCNQ1 (KV7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter Mol. Pharmacol. 71 2007 1503 1511
111. KS potassium channel: an overlooked cardiovascular liability in drug safety screening? J. Pharmacol. Toxicol. Methods 60 2009 1 10
112. + channel-drug interactions by ancillary subunits J. Physiol. 586 2008 929 950
113. + channels in neuronal cells Eur. J. Pharmacol. 336 1997 243 249
114. M.J. Main et al. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine Mol. Pharmacol. 58 2000 253 262
115. C. Rundfeldt, and R. Netzer The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits Neurosci. Lett. 282 2000 73 76
116. A.D. Wickenden et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels Mol. Pharmacol. 58 2000 591 600
117. L. Tatulian et al. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine J. Neurosci. 21 2001 5535 5545
118. L. Tatulian, and D.A. Brown Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells J. Physiol. 549 2003 57 63
119. J.W. Dailey et al. Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response Neurosci. Lett. 195 1995 77 80
120. C. Tober et al. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures Eur. J. Pharmacol. 303 1996 163 169
121. A. Rostock et al. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures Epilepsy Res. 23 1996 211 223
122. + channel sensitivity to the anticonvulsant retigabine J. Neurosci. 25 2005 5051 5060
123. T.V. Wuttke et al. The new anticonvulsant retigabine favors voltage-dependent opening of the KV7.2 (KCNQ2) channel by binding to its activation gate Mol. Pharmacol. 67 2005 1009 1017
124. + channels Mol. Pharmacol. 75 2009 272 280
125. B.H. Bentzen et al. The acrylamide (S)-1 differentially affects KV7 (KCNQ) potassium channels Neuropharmacology 51 2006 1068 1077
126. A.D. Wickenden et al. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator Mol. Pharmacol. 73 2008 977 986
127. S.M. Blom et al. Differential effects of ICA-27243 on cloned KV7 channels Pharmacology 86 2010 174 181
128. K. Padilla et al. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site Neurosci. Lett. 465 2009 138 142
129. Q. Xiong et al. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants Nat. Chem. Biol. 3 2007 287 296
130. Q. Xiong et al. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers Proc. Natl. Acad. Sci. U. S. A. 105 2008 3128 3133
131. + currents Mol. Pharmacol. 54 1998 220 230
132. S. Ohya et al. Molecular variants of KCNQ channels expressed in murine portal vein myocytes: a role in delayed rectifier current Circ. Res. 92 2003 1016 1023
133. S.Y. Yeung, and I.A. Greenwood Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells Br. J. Pharmacol. 146 2005 585 595
134. P.S. Chadha et al. Pharmacological dissection of KV7.1 channels in systemic and pulmonary arteries Br. J. Pharmacol. 166 2012 1377 1387
135. A.R. Mackie, and K.L. Byron Cardiovascular KCNQ (KV7) potassium channels: physiological regulators and new targets for therapeutic intervention Mol. Pharmacol. 74 2008 1171 1179
136. + channel KCNQ genes in human arteries Br. J. Pharmacol. 162 2011 42 53
137. I.A. Greenwood, and S. Ohya New tricks for old dogs: KCNQ expression and role in smooth muscle Br. J. Pharmacol. 156 2009 1196 1203
138. S. Joshi et al. KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle J. Pharmacol. Exp. Ther. 329 2009 368 376
139. V7.4 channel activity in primary and secondary hypertension Circulation 124 2011 602 611
140. P.S. Chadha et al. Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired beta-adrenoceptor-mediated relaxation of renal arteries in hypertension Hypertension 59 2012 877 884
141. S. Khanamiri et al. Contribution of KV7 channels to basal coronary flow and active response to ischemia Hypertension 2013 10.1161/HYPERTENSIONAHA.113. 01244
142. L.I. Brueggemann et al. Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells Am. J. Physiol. Heart Circ. Physiol. 292 2007 H1352 H1363
143. A.R. Mackie et al. Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance J. Pharmacol. Exp. Ther. 325 2008 475 483
144. J. Schleifenbaum et al. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulphide J. Hypertens. 28 2010 1875 1882
145. S. Ohya et al. Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle Am. J. Physiol. Gastrointest. Liver Physiol. 282 2002 G277 G287
146. V7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus Pharmacol. Res. 64 2011 397 409
147. + channel in murine gastrointestinal smooth muscles Am. J. Physiol. Gastrointest. Liver Physiol. 297 2009 G107 G115
148. F. Rode et al. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder Eur. J. Pharmacol. 638 2010 121 127
149. U.A. Anderson et al. Functional expression of KCNQ (KV7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity Br. J. Pharmacol. 169 2013 1290 1304
150. + channel (KCNQ) opener retigabine in freely moving, conscious rats J. Urol. 172 2004 2054 2058
151. V7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy Am. J. Physiol. Lung Cell. Mol. Physiol. 302 2012 L120 L132
152. V7 channels to pregnant mouse and human myometrial contractility J. Cell. Mol. Med. 15 2011 577 586
153. W.M. Herrmann et al. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an on going twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis Postgrad. Med. 63 Suppl. 3 1987 87 103
154. + currents Br. J. Pharmacol. 155 2008 62 72
155. S. Joshi et al. Pulmonary vasoconstrictor action of KCNQ potassium channel blockers Respir. Res. 7 2006 31
156. I. Morecroft et al. Treatment with the KV7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension Br. J. Pharmacol. 157 2009 1241 1249
157. X.Z. Zhong et al. Participation of KCNQ (KV7) potassium channels in myogenic control of cerebral arterial diameter J. Physiol. 588 2010 3277 3293
158. V7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery Br. J. Pharmacol. 164 2011 237 249
159. V7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm J. Cardiovasc. Pharmacol. 61 2013 51 62
160. G.K. Owens et al. Molecular regulation of vascular smooth muscle cell differentiation in development and disease Physiol. Rev. 84 2004 767 801
161. B.R. Wamhoff et al. Excitation-transcription coupling in arterial smooth muscle Circ. Res. 98 2006 868 878
162. L.A. Martinez-Lemus Persisten agonist-induced vasoconstriction is not required for angiotensin II to mediate inward remodeling of isolated arterioles with myogenic tone J. Vasc. Res. 45 2008 211 221